Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Alemtuzumab for refractory celiac disease.
Verbeek WH, Mulder CJ, Zweegman S. Verbeek WH, et al. N Engl J Med. 2006 Sep 28;355(13):1396-7; author reply 1397. doi: 10.1056/NEJMc061784. N Engl J Med. 2006. PMID: 17005966 No abstract available.
Update on the management of refractory coeliac disease.
Al-Toma A, Verbeek WH, Mulder CJ. Al-Toma A, et al. J Gastrointestin Liver Dis. 2007 Mar;16(1):57-63. J Gastrointestin Liver Dis. 2007. PMID: 17410290 Review.
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.
Al-toma A, Visser OJ, van Roessel HM, von Blomberg BM, Verbeek WH, Scholten PE, Ossenkoppele GJ, Huijgens PC, Mulder CJ. Al-toma A, et al. Blood. 2007 Mar 1;109(5):2243-9. doi: 10.1182/blood-2006-08-042820. Epub 2006 Oct 26. Blood. 2007. PMID: 17068146 Clinical Trial.
Evaluation of Cladribine treatment in refractory celiac disease type II.
Tack GJ, Verbeek WH, Al-Toma A, Kuik DJ, Schreurs MW, Visser O, Mulder CJ. Tack GJ, et al. World J Gastroenterol. 2011 Jan 28;17(4):506-13. doi: 10.3748/wjg.v17.i4.506. World J Gastroenterol. 2011. PMID: 21274381 Free PMC article. Clinical Trial.
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy.
Tack GJ, Wondergem MJ, Al-Toma A, Verbeek WH, Schmittel A, Machado MV, Perri F, Ossenkoppele GJ, Huijgens PC, Schreurs MW, Mulder CJ, Visser OJ. Tack GJ, et al. Bone Marrow Transplant. 2011 Jun;46(6):840-6. doi: 10.1038/bmt.2010.199. Epub 2010 Sep 6. Bone Marrow Transplant. 2011. PMID: 20818442 Clinical Trial.
The management of complicated celiac disease.
Al-toma A, Verbeek WH, Mulder CJ. Al-toma A, et al. Dig Dis. 2007;25(3):230-6. doi: 10.1159/000103891. Dig Dis. 2007. PMID: 17827946
The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
Verbeek WH, von Blomberg BM, Scholten PE, Kuik DJ, Mulder CJ, Schreurs MW. Verbeek WH, et al. Am J Gastroenterol. 2008 Dec;103(12):3152-8. doi: 10.1111/j.1572-0241.2008.02213.x. Am J Gastroenterol. 2008. PMID: 19086962
Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M, Al-Toma A, Schreurs MW, Mulder CJ. Verbeek WH, et al. Clin Immunol. 2008 Jan;126(1):48-56. doi: 10.1016/j.clim.2007.09.002. Epub 2007 Nov 26. Clin Immunol. 2008. PMID: 18024205
[Diarrhoea and malabsorption due to olmesartan use].
van Beurden YH, Nijeboer P, Janssen J, Verbeek WH, Mulder CJ. van Beurden YH, et al. Ned Tijdschr Geneeskd. 2014;158:A7370. Ned Tijdschr Geneeskd. 2014. PMID: 24780574 Dutch.
Enteropathy associated T-cell lymphoma and its precursor lesions.
van de Water JM, Cillessen SA, Visser OJ, Verbeek WH, Meijer CJ, Mulder CJ. van de Water JM, et al. Best Pract Res Clin Gastroenterol. 2010 Feb;24(1):43-56. doi: 10.1016/j.bpg.2009.11.002. Best Pract Res Clin Gastroenterol. 2010. PMID: 20206108 Review.
40 results
Jump to page
Feedback